Are there any risks with combining these treatments
Who Is Well-Suited Patients in the early-to-mid phase of GLP-1 treatment represent the strongest candidates for a concurrent photobiomodulation protocol specifically those who want to proactively support their skins collagen biology and lean mass during the loss process, and those with mild-to-moderate laxity (skin that feels loose or less firm but does not involve significant excess skin surface area)
Chromium - Supports the Metabolism and Storage of Carbohydrates, Fats & Proteins in the Body*
However, these medications also typically produce less dramatic weight loss, which is likely the key factor
Disclosures Dr Moradi is a consultant, advisor and clinical research investigator for AbbVie (North Chicago, IL), Evolus (Newport Beach, CA), Galderma (Lausanne, Switzerland), Merz (Raleigh, NC), and Teoxane (Geneva, Switzerland)
For example, a 2019 study found that eating a whole avocado with a meal elevated levels of GLP-1 and peptide YY (another hormone tied to fullness), while also lowering insulin levels